Difference between revisions of "PDFF Biomarker Ctte"
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
| + | *[[Media:2018_08-02_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|August 2, 2018]] | ||
*[[Media:2018_05-03_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|May 3, 2018]] | *[[Media:2018_05-03_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|May 3, 2018]] | ||
*[[Media:2018_04-05_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|April 5, 2018]] | *[[Media:2018_04-05_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|April 5, 2018]] | ||
| − | |||
'''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | '''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | ||
Revision as of 20:35, 13 September 2018
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- Secretary: Susan Stanfa
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Meetings
Approved call summaries:
PDFF Biomarker Committee Call Summaries Archive